How do I buy Trevi Therapeutics, Inc. Common Stock (TRVI) stock?

Buying Trevi Therapeutics, Inc. Common Stock (TRVI) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "TRVI", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy TRVI by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if TRVI is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trevi Therapeutics, Inc. Common Stock (TRVI) Stock

Q: What is the minimum investment for TRVI on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Trevi Therapeutics, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · TRVI

Trade TRVI

Key stats

Market cap: $2.11B
Price / Earnings ratio: -35.0x
EPS (TTM): -$0.39
Volume: Loading
52-week high: $20.22
52-week low: $9.82
Next earnings report: 12 Nov 2026

Source: third-party data provider, as of November 13, 2026

Compare with TRVI

Technical indicators

RSI 14: 58.65
MACD 12/26/9: 0.22
EMA 9 of MACD: -0.07
MACD histogram: 0.29
SMA 50: $14.17; Price above SMA 50
EMA 50: $14.30; Price above EMA 50
SMA 200: $14.49; Price above SMA 200
EMA 200: $13.99; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 1 analyst rating

Strong Sell0

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

0000

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

232M153M77M0

Revenue to Profit

2025

$0.0

Revenue

$0.0

Cost of revenue

$0.0

Gross profit

$0.0

Operating expenses

$-42.8M

Net income

Earnings

EPS forecast

Actual EPS

$-0.10

Q4FY25

$-0.12

Q1FY26

$-0.13

Q2FY26

$-0.15

Q3FY26

The market is expecting earnings per share of -$0.15 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Trevi Therapeutics, Inc. Common Stock

No description available.

SectorHealthcare

IndustryBiotechnology

Employees34

CEOMs. Jennifer L. Good

IPO DateMay 2, 2019

HeadquartersNew Haven, CT

Key Executives

Name	Title	Year Born
Ms. Jennifer L. Good	Co-Founder, CEO, President, & Director	1965
Mr. David C. Hastings CPA	Chief Financial Officer & Principal Financial Officer	1961
Dr. James V. Cassella Ph.D.	Chief Development Officer	1955
Dr. Thomas R. Sciascia M.D.	Co-Founder & Chief Scientific Officer	1953
Mr. Christopher Galletta	Controller & Chief Accounting Officer	1978
Katie McManus	Communications Manager	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-10.0	-21.2
2022	-19.0	-8.6	+152.9	+42.1	-3.6	+15.6	+4.8	-1.2	-51.0	+23.0	-6.0	+1.0
2023	+14.8	+2.6	-23.2	+82.0	-35.3	+10.6	+0.4	-10.5	-5.2	-12.3	-35.8	+20.7
2024	+9.2	+110.1	+17.7	-12.8	-10.1	+16.9	+10.0	+1.9	+12.5	-5.1	-4.3	+44.1
2025	-9.6	+7.1	+47.7	+15.0	-5.7	-13.4	+30.0	-1.0	+25.9	+24.0	+23.3	-5.9
2026	-11.9	+8.8	-5.1	+18.8	+1.9	+33.7	+3.6	-7.3	-13.6	-4.4	+8.7

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Trevi Therapeutics, Inc. Common Stock (TRVI) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "TRVI", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy TRVI by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Trevi Therapeutics, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Trevi Therapeutics, Inc. Common Stock (TRVI) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track TRVI's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Trevi Therapeutics, Inc. Common Stock (TRVI) Stock

Key stats

Compare with TRVI

Recent news

Trevi Therapeutics Q2 Earnings Call Highlights

Trevi Therapeutics Q2 Earnings Call Highlights

Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.

Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.

Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030

Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030

TRVI Stock’s Five-Day Rally Pushes It To An All-Time High – Here’s What’s Happening

TRVI Stock’s Five-Day Rally Pushes It To An All-Time High – Here’s What’s Happening

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Trevi Therapeutics Q2 Earnings Call Highlights

Trevi Therapeutics Q2 Earnings Call Highlights

Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.

Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.

Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030

Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030

TRVI Stock’s Five-Day Rally Pushes It To An All-Time High – Here’s What’s Happening

TRVI Stock’s Five-Day Rally Pushes It To An All-Time High – Here’s What’s Happening

TRVI Stock Slips After Company Plans Parallel Trials In Lung Disease — Stifel Dismisses Timeline Concerns

TRVI Stock Slips After Company Plans Parallel Trials In Lung Disease — Stifel Dismisses Timeline Concerns

Up Over 50%: 3 Stocks on the Verge of a Massive Breakout in March

Up Over 50%: 3 Stocks on the Verge of a Massive Breakout in March

Does Trevi Therapeutics (TRVI) Have the Potential to Rally 102.07% as Wall Street Analysts Expect?

Does Trevi Therapeutics (TRVI) Have the Potential to Rally 102.07% as Wall Street Analysts Expect?

About Trevi Therapeutics, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade